Goldman Sachs Gets Regulatory Approval for Fund Sales in China
Werte in diesem Artikel
The Goldman Sachs Group, Inc. GS has obtained regulatory approvals from the Beijing Bureau of China Securities Regulatory Commission to sell funds in China. This was first reported by Reuters.The license was granted to GS’s China securities brokerage unit. This marks a significant step for the U.S. investment bank in the China market.With this, Goldman Sachs has become the latest U.S. investment bank to get a financial license, which is a sign of Beijing's commitment to continue opening the sector to foreign companies.The license to Goldman Sachs follows Morgan Stanely MS, which received the final approval last month to begin a futures business in China through a newly established unit. The growing prospects for international financial institutions in China's sizable market are demonstrated by these licenses.GS’s Efforts to Focus on IB & Trading OperationsGoldman decided to refocus on its core strengths of IB and trading operations while scaling back its consumer banking footprint. Hence, it undertook a major business restructuring initiative. In October 2024, Barclays finalized a deal to acquire Goldman’s General Motors credit card business. In the first quarter of 2024, GS completed the sale of GreenSky, its home-improvement lending platform, to a consortium of investors.In the fourth quarter of 2023, Goldman sold its Personal Financial Management unit to Creative Planning. Goldman aims to cease unsecured loan offerings to consumers through its digital consumer banking platform — Marcus. In 2023, it sold substantially all of Marcus’s loan portfolio.These moves are in line with Goldman's decision to focus on and grow core businesses, wherein it has showcased encouraging results, given its strong leadership position, wide scale of operations and exceptional talent.Goldman’s Price Performance & Zacks RankOver the past six months, GS shares have gained 30.3% compared with the industry’s 24.4% growth. Image Source: Zacks Investment Research Currently, Goldman Sachs carries a Zacks Rank #3 (Hold).Goldman’s Peers Worth ConsideringSome better-ranked stocks are Raymond James Financial Inc. RJF and Bank of America Corporation BAC.Raymond James Financial’s earnings estimates for 2024 have been revised upward to $10.85 per share in the past 30 days. RJF shares have gained 36.1% over the past six months. It currently sports a Zacks Rank of 1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here.Bank of America’s 2024 earnings estimates have been unchanged at $3.27 per share in the past 30 days. BAC shares have gained 16.2% over the past six months. It currently carries a Zacks Rank of 2 (Buy).7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report Bank of America Corporation (BAC): Free Stock Analysis Report Morgan Stanley (MS): Free Stock Analysis Report Raymond James Financial, Inc. (RJF): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Goldman Sachs
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Goldman Sachs
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Goldman Sachs
Analysen zu Goldman Sachs
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2024 | Goldman Sachs Buy | Jefferies & Company Inc. | |
15.10.2024 | Goldman Sachs Overweight | JP Morgan Chase & Co. | |
15.07.2024 | Goldman Sachs Buy | Jefferies & Company Inc. | |
15.07.2024 | Goldman Sachs Sector Perform | RBC Capital Markets | |
16.01.2024 | Goldman Sachs Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
16.10.2024 | Goldman Sachs Buy | Jefferies & Company Inc. | |
15.10.2024 | Goldman Sachs Overweight | JP Morgan Chase & Co. | |
15.07.2024 | Goldman Sachs Buy | Jefferies & Company Inc. | |
16.01.2024 | Goldman Sachs Buy | Jefferies & Company Inc. | |
16.01.2024 | Goldman Sachs Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2024 | Goldman Sachs Sector Perform | RBC Capital Markets | |
17.10.2023 | Goldman Sachs Sector Perform | RBC Capital Markets | |
18.01.2022 | Goldman Sachs Neutral | UBS AG | |
13.07.2021 | Goldman Sachs Sector Perform | RBC Capital Markets | |
19.01.2021 | Goldman Sachs Sector Perform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
19.10.2017 | Goldman Sachs Sell | Société Générale Group S.A. (SG) | |
24.02.2017 | Goldman Sachs Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.01.2017 | Goldman Sachs Sell | Citigroup Corp. | |
06.05.2016 | Goldman Sachs Sell | Société Générale Group S.A. (SG) | |
01.03.2016 | Goldman Sachs Sell | Société Générale Group S.A. (SG) |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Goldman Sachs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen